Supplemental material
Open access
2,730
Views
8
CrossRef citations to date
0
Altmetric
Research Article
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
Prashant Kumara Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Ravi S. Shuklaa Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Ashaben Patela Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Swathi R. Pullagurlaa Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Christopher Birda Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Oluwadara Oguna Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Ozan S. Kumrua Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USAView further author information
, Ahd Hamidib Batavia Biosciences B.V., Bioscience Park Leiden, Leiden, The NetherlandsView further author information
, Femke Hoeksemab Batavia Biosciences B.V., Bioscience Park Leiden, Leiden, The NetherlandsView further author information
, Christopher Yallopb Batavia Biosciences B.V., Bioscience Park Leiden, Leiden, The NetherlandsView further author information
, Julie E. Binesc Murdoch Children’s Research Institute, Department of Paediatrics, University of Melbourne, Parkville, Australia;d Department of Gastroenterology and Clinical Nutrition, Royal Children’s Hospital, Parkville, AustraliaView further author information
, Sangeeta B. Joshia Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USACorrespondence[email protected]
View further author information
& View further author information
David B. Volkina Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 2298-2310
|
Received 01 Oct 2020, Accepted 29 Jan 2021, Published online: 16 Apr 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.